Amgen has agreed to a $74 million settlement with investors who allege that the company hid a massive U.S. tax bill from the ...

Following an inspection earlier this year that yielded a Form 483, Indian generics juggernaut Alembic Pharmaceuticals has ...

Detailed phase 3 results suggest the two-drug combination of Gilead Sciences’ lenacapavir and Merck & Co.’s islatravir has ...

Novartis' CEO remains unfazed by the threat of a newly approved oral PCSK9 inhibitor in Merck & Co.’s Lipfendra, doubling ...

Novo Nordisk has accused Eli Lilly of running ad campaigns containing “deliberately false” messages that mislead the public ...

South Korean contract manufacturer Samsung Biologics hopes to tap into the booming peptide production and weight loss market with plans to buy out Switzerland-based CDMO PolyPeptide for 1.46 billion ...

On paper, it was another strong quarter for Carvykti. Johnson & Johnson reported record sales for the CAR-T therapy, ...

The campaign is one of weight loss app Noom's largest brand investment to date and features two TV spots and new in-app ...

After nearly a century of naming its Person of the Year each December, Time is adding another prestigious recognition with help from Johnson & Johnson. J&J and Time are teaming up to honor a ...

Pacira BioSciences, Inc., an innovative biopharmaceutical company, focuses on non-opioid therapies that address a diverse range of musculoskeletal pain needs, including chronic and post-surgery pain.

Since reaching the market a decade ago, PCSK9 inhibitors have not lived up to their lofty expectations. | The FDA has ...

From Indiana to Iceland, the FDA this week disclosed concerns raised during recent visits to a pair of manufacturing sites ...